Lifecore Biomedical, Inc. (LFCR)
(Delayed Data from NSDQ)
$7.87 USD
-0.06 (-0.76%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $7.86 -0.01 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
LFCR 7.87 -0.06(-0.76%)
Will LFCR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LFCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFCR
Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock?
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates
LFCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
ImmunityBio (IBRX) Reports Q2 Loss, Tops Revenue Estimates
Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
Other News for LFCR
LFCR forms Bearish Engulfing on September 19
Is LFCR showing upside potential? New Uptrend shows up after gaining 2.99%
The technical outlook for LFCR is unchanged after it falls 2.04% on September 17
Is LFCR getting ready to pop? Calm After Storm shows up after gaining 2.34%
20 Day Moving Average Support appears for LFCR after 2.13% move